Clinuvel Pharmaceuticals buy Savour
Start price
20.03.19
/
50%
€16.90
Target price
07.12.19
-
Performance (%)
-1.89%
End price
07.12.19
€16.58
Summary
This prediction ended on 07.12.19 with a price of €16.58. With a performance of -1.89%, the BUY prediction by Savour finished with a loss. A total of €0.015 was paid as dividends for this prediction. Savour has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | 1.312% | 1.312% | -7.198% | -45.490% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Savour for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
Savour stimmt der Buy-Einschätzung von Maxi-Scalibusa zu
Savour stimmt am 20.03.2019 der Buy-Einschätzung von Maxi-Scalibusa mit dem Kursziel 19,5€ zu.
Überschrift: Highflyer
Stopped prediction by Savour for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€17.85
22.12.19
22.12.19
-
11.07.20
11.07.20
-23.08%
11.07.20
11.07.20
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€16.60
07.12.19
07.12.19
-
22.12.19
22.12.19
7.53%
22.12.19
22.12.19